Scientific Reports · 2022 · 40 citations · 45 references
MedicineOncologyUrologyMass Spectrometric AnalysisMetabolomicsUrologic OncologyBladder CancerCancer BiomarkersCancer MetabolomicsMetabolic EvaluationMetabolite ProfilingUntargeted MetabolomicsBladder Cancer DiagnosisBladder Cancer Recurrence BiomarkersClinical Metabolite ProfilingHigh-performance Liquid ChromatographyHigh-resolution SpectrometryMass Spectrometry-based Metabolite ProfilingNon-invasive ExaminationUltra-performance Liquid Chromatography-mass Spectrometry
Bladder cancer (BC) is a common urological cancer of high mortality and recurrence rates. Currently, cystoscopy is performed as standard examination for the diagnosis and subsequent monitoring for recurrence of the patients. Frequent expensive and invasive procedures may deterrent patients from regular follow-up screening, therefore it is important to look for new non-invasive methods to aid in the detection of recurrent and/or primary BC. In this study, ultra-high-performance liquid chromatography coupled with ultra-high-resolution mass spectrometry was employed for non-targeted metabolomic profiling of 200 human serum samples to identify biochemical signatures that differentiate BC from non-cancer controls (NCs). Univariate and multivariate statistical analyses with external validation revealed twenty-seven metabolites that differentiate between BC patients from NCs. Abundances of these metabolites displayed statistically significant differences in two independent training and validation sets. Twenty-three serum metabolites were also found to be distinguishing between low- and high-grade of BC patients and controls. Thirty-seven serum metabolites were found to differentiate between different stages of BC. The results suggest that measurement of serum metabolites may provide more facile and less invasive diagnostic methodology for detection of bladder cancer and recurrent disease management.
45
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita, Seung‐Yeol Park, Tadashi Nishio et al. · Scientific Reports · 2017 · 16.1K citations · Full text
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
Zhiqiang Pang, Jasmine Chong, Guangyan Zhou et al. · Nucleic Acids Research · 2021 · 4.1K citations · Full text
KEGG Atlas mapping for global analysis of metabolic pathways
Shujiro Okuda, Takuji Yamada, Masami Hamajima et al. · Nucleic Acids Research · 2008 · 517 citations · Full text
Marianne C. Walsh, Lorraine Brennan, J. Paul G. Malthouse et al. · American Journal of Clinical Nutrition · 2006 · 291 citations · Full text